Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Anesthesia + PAI vs PAI Alone After TKA
NCT06410612Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Visual Analog Scale Pain Score at 2 weeks. Started Mar 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06410612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06410612.